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Abstract Here we studied the glycosylation of a mammalian 
protein, the ectodomain of rat nerve growth factor receptor 
(NGFRe), in Saccharomyces cerevisiae. NGFR~ is secreted to 
the culture medium of S. cerevisiae if it is fused to a polypeptide 
(hspl50A) carrier. The hspl50A-carrier has 95 serine and 
threonine residues, which were extensively O-glycosylated. In 
spite of 41 potential sites, NGFRe lacked O-glycans, whether 
fused to the carrier or not. Distortion of the conformation of 
N GFRe by inhibition of disulfide formation did not promote O- 
glycosylation, whereas N-glycosylation was enhanced. Thus, the 
serine and threonine residues of the hspl50A-NGFRe fusion 
protein were highly selectively O-glycosylated. 
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1 Introduction 
In mammalian cells, O-glycans are initiated in the Golgi by 
N-acetylgalactosamine, and vary in composition and length 
[ ,2]. Since selected serines and threonines obtain glycans, 
O-glycosylation must be controlled by specific features of 
the folded molecules. In yeast, O-glycosylation begins in the 
e ldoplasmic reticulum (ER) by transfer of a single mannose 
r~,'sidue from dolichol monophosphate to a serine or threonine 
r~'sidue, followed by chain elongation up to pentamannosides 
i~l the Golgi [3-7]. Since no consensus equence for O-glyco- 
sAation has been identified, mannosylation of an unfolded 
polypeptide in the process of translocation across the ER 
raembrane should be less selective than mannosylation of a 
t )lded molecule. We have recently shown that the extracellu- 
ltr domain of rat low-affinity nerve growth factor receptor 
(~IGFRe) [8] folded to a ligand-binding conformation and 
was efficiently secreted to the culture medium of Saccharo- 
myces cerevisiae, but only when fused to the C-terminus of 
t ie  hsp150A-carrier [9], an N-terminal fragment of the natural 
s,~cretory protein hsp150 [10-12]. Here we studied the glyco- 
svlation of the NGFRe portion. Since the hspl50A-carrier is
e~tensively O-glycosylated [11], the hspl50A-NGFRe fusion 
l'rotein provided us with a tool to study selectivity of O-gly- 
asylation in yeast. 
2. Materials and methods 
2.1. Strains and media 
Plasmid propagation was in Escherichia coli DH5s, grown in L- 
broth supplemented with 100 I.tg/ml of ampicillin. S. cerevisiae strains 
H23 (Mats hsp150: :URA3 his3-11,15 leu2-3, 112 trpl-1 ade2-1 canl- 
100), H426 (MATs ade2-101 suc2A9 gal2, hsp150: : URA3 
LEU2: :HSP150A-NGFRe), H538 (Mats secl8-1 trpl-289 
hsp150: : URA3 his- LEU2: :HSP15OA-NGFRe) and H451 (H23, 
LEU2::HSP150AfXa-NGFRe) were grown at 24°C in YPD medium, 
and strains H487 (H23, [pKTH4616]) and H640 (Mats sec18-1 trp1- 
289 leu2-1,112 his- hsp150::URA3 [pKTH4616]) [9] in synthetic 
complete medium lacking tryptophan. 
2.2. Plasmid construction 
To construct a cleavage site between the hsp150A-carrier and 
NGFR~, oligonucleotides 5'-GTACCATCGAAGGTAGAG and 5'- 
GTACCTCTACCTTCGATG coding for the recognition site of fac- 
tor Xa (IEGR), and containing Asp718-compatible ends, were allowed 
to anneal, and were ligated to Asp718-digested pKTH4594 [9]. The 
new plasmid was named pKTH4610, and the construction verified by 
sequencing. The HSP15OA-NGFR e fragment was detached from 
pKTH4610 as a 3.3 kb EeoRV-Spel fragment, he SpeI site was filled 
in with Klenow polymerase, and the fragment was ligated to the Sinai 
site of pFL26 [13]. Strain H23 was transformed with the resulting 
plasmid pKTH4612, creating H451. 
2.3. Metabolic labeling and immunoprecipitation 
Metabolic labeling of cells (2;< 108 cells/400 lal) was with 20 laCi of 
[aSS]Met/Cys (1000 Ci/mmol), or with 100 ~tCi of [3H]mannose (18 Ci/ 
mmol) (Amersham, UK). For 3~S-labeling, the cells were grown and 
labeled in synthetic omplete medium lacking methionine and cy- 
steine. For 3H-labeling, cell growth was in full (2%) glucose, and 
labeling was in 0.1% glucose. The expression of SUC-NGFRe was 
induced by 0.1% glucose due to the SUC promoter [9]. Lysis of cells 
and immunoprecipitations with the polyclonal rabbit antisera nti- 
hspl50 (1:100), anti-NGFR (1:50; raised against he ligand-binding 
domain of authentic NGFR) and anti-hsp150A-NGFRe (1 :50) were as 
described [14]. 
2.4. Other methods 
Culture medium samples were concentrated using Centricon-30 
(Amicon) devices, diluted in 50 mM Tris-HCl, pH 8.3, containing 
0.9% NaCI (factor Xa buffer), and digested with factor Xa (Boehrin- 
ger, Mannheim) at 24°C. Western analysis was performed as before 
[14]. SDS-polyacrylamide gelelectrophoresis (SDS-PAGE) was in 8% 
gels, if not otherwise stated. Trichloroacetic acid (14%) precipitation 
was for 1 h on ice. Cycloheximide, NAN3, tunicamycin and dithio- 
threitol were from Sigma, and used at concentrations of 100 p.g/ml, 10 
mM, 20 ~tg/ml and 20 mM, respectively. Restriction endonucleases 
were from Promega, New England Biolabs and Boehringer Mann- 
helm. 
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3. Results and discussion 
3.1. Synthesis and secretion of  hspl 5OA-fXa-NGFl~ 
The hspl50A-carrier has no potential N-glycosylation sites, 
whereas many of its 95 serines and threonines carry O-glycans 
containing 2-5 mannose residues [11]. The NGFRe portion 
has 41 potential O-glycosylation sites and one N-glycosylation 
site. To study whether the NGFRe portion was also O-glyco- 
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Fig. 1. (A) Hspl50A-fXa-NGFRe consists of the hspl50A-carrier 
(amino acids 1-321) and the whole extracellular domain of mature 
NGFRe (amino acids 328-550 of the fusion protein), joined by the 
factor Xa recognition site IEGR plus a GT-linker. The hsp150A-car- 
rier consists of a signal peptide (amino acids 1-18), subunit I (ami- 
no acids 19-72) and subunit II, which consists mainly of 11 repeats 
of a homologous peptide (amino acids 73-321). (B) In hsp150A- 
NGFRe the carrier and NGFRe are joined directly to each other. 
(C) NGFR~ (amino acids 25-246) is preceded by the 22 first amino 
acids of pre-invertase plus a GT linker. The cysteine residues (ar- 
rows) and the N-glycosylation site (N) are indicated. 
sylated, we needed to release it from the carrier. For this 
purpose, a DNA fragment encoding the proteolytic leavage 
site for the blood clotting factor X~ was engineered between 
the DNA fragments coding for the carrier and NGFR¢ (Fig. 
1A). The fusion gene was targetted to the leu2 locus of 
S. cerevisiae to create strain H451. The cells were labeled 
with [35S]Met/Cys, followed by chase with cycloheximide 
(CHX). Anti-hsp150 antiserum precipitated heterogenous 
hspl50A-fX~-NGFRe molecules from the culture medium 
(Fig. 2, lane 1), whereas only a little was immunoprecipitated 
from the cell lysate (lane 3). The secreted (lane 2) and cell- 
associated (lane 4) protein was recognized by anti-NGFRe 
antiserum raised against authentic NGFR, although poorly. 
When labeling was performed in the presence of tunicamycin 
(TM) to inhibit N-glycosylation, similar results were obtained, 
except hat secreted hspl50A-NGFRe was more homogenous 
and migrated like a 180 kDa protein (Fig. 2, lanes 5-8). A 130 
kDa protein, the ER form (see below), was detected in the cell 
lysate (lane 7). Thus, hspl50A-fX~-NGFR~ was secreted 
nearly as efficiently in the absence of N-glycosylation, as in 
its presence. Antiserum raised against hsplSOA-NGFRe [9] 
recognized NGFR~ much better than anti-NGFR~, and was 
used henceforth. 
3.2. Release of NGFI~ from the carrier 
Hspl50A-fXa-NGFRe, [z~S]Met/Cys-labeled in the presence 
of TM, was harvested from the culture medium of H451 cells 
and subjected to factor X~ digestion. The digests were tri- 
chloroacetic acid-precipitated and analyzed in SDS-PAGE. 
Immunoprecipitation was omitted, since the fusion protein 
was the major radiolabeled protein in the medium (Fig. 3A, 
lane 1). With increasing digestion time and enzyme concentra- 
tions, products of 48 and 36 kDa appeared at the expense of 
the intact fusion protein (lanes 2-5). The 48 and 36 kDa 
products were recognized in Western analysis by anti- 
hspl50A-NGFRe antiserum, but neither of them by anti- 
hspl50 antiserum, whereas the intact fusion protein was rec- 
ognized by both (not shown). The 48 kDa form most prob- 
ably was the correct product, NGFR~, because it had the 
expected size [15]. Moreover, NGFR~ expressed in the absence 
of the hspl50A-carrier by the aid of the invertase signal pep- 
tide also migrated like a 48 kDa protein (see below). Cleavage 
at the factor Xa site apparently made a secondary cleavage 
site in the NGFRe portion available, since hsplSOA-NGFR 
lacking the cleavage site (Fig. 1B) was not susceptible to fac- 
tor X~ (not shown). The secondary cleavage apparently was at 
the cysteine-free C-terminus of the NGFR~ portion, since the 
36 kDa product appeared to contain a similar amount of 3~S- 
radioactivity as the intact hsplSOA-fX~-NGFRe fusion protein 
(compare lanes 1,5 in Fig. 3A). Since all methionines, and 24 
out of the 25 cysteine residues of the fusion protein were in 
the NGFRe portion, the released hsplSOA-carrier was not 
visible in the fluorogram. Factor X~ cleavage of N-glycosy- 
lated hsp150A-fX~-NGFRe gave essentially similar results (not 
shown). 
3.3. Glycosylation of NGFRe 
To study whether the NGFR~ portion of hspl50A-fXa- 
NGFRe was O-glycosylated, strain H451 was labeled with 
[3H]mannose in the presence of TM. The secreted fusion pro- 
tein was digested with factor Xa as above. SDS-PAGE ana- 
lysis revealed a single product at the top of the separating el 
(Fig. 3B, lanes 2,3). This was the hspl50A-carrier, as we have 
shown before by synthesizing it from a truncated HSP150A 
gene [11]. The carrier barely penetrated an 8% gel, although 
the molecular mass of the polypeptide is 23.7 kDa. This was 
due to its extended structure and O-glycosylation [11]. Since 
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Fig. 2. Secretion of hsp150A-fXa-NGFRe. H451 cells were labeled 
with [3~S]Met/Cys at for 1 h 24°C in the absence (lanes 1-4) or pre- 
sence of TM (lanes 5 8). Culture medium samples (M) (lanes 
1,2,5,6) and lysed cell samples (C) (lanes 3,4,7,8) were immunopreci- 
pitated with anti-bspl50 (lanes 1,3,5,7) or anti-NGFRe antiserum 
(lanes 2,4,6,8), and analyzed by SDS-PAGE and fluorography. Mo- 
lecular weight markers (kDa) are on the left. 
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F g. 3. Digestion of hsp150-fX~-NGFRe with factor Xa. (A) Strain 
I-t451 was preincubated with TM for 10 min, and labeled with 
[3 S]Met/Cys in the presence of TM at 37°C for 60 min. In (B) the 
labeling was with [3H]mannose for 90 min. The culture medium 
s:~mples were subjected to factor Xa digestions as indicated. The di- 
gests were trichloroacetic acid-precipitated and analyzed by SDS- 
P~,GE (7.5-15% gel) and ttuorography. The arrowheads between 
tl~e panels indicate the hspl50A-carrier, intact hspl50A-fX~-NGFRe 
of 180 kDa, and the products of 46 and 38 kDa. The arrows indi- 
c::te the border of the stacking and separating els. Molecular 
x~ eight markers are on the left. 
n 9 [3H]mannose-labeled 48 or 36 kDa products were detected, 
ti~e NGFRe portion had very few if any O-glycans, in spite of 
t~ amerous potential sites, and extensive O-glycosylation of the 
ctrrier fragment. 
NGFR~ was then synthesized without the hspl50A-carrier 
u~ing the invertase signal peptide (Fig. 1C). NGFRe (strain 
Iq487) was [3~S]Met/Cys-labeled in the absence (Fig. 4A, lane 
1~ or presence of TM (lane 2). Parallel cells were 
[H]mannose-labeled in the absence (lane 3) or presence of 
"IM (lane 4). Immunoprecipitation with anti-hsp 150A-NGFR~ 
a ntiserum and SDS-PAGE analysis revealed, as shown before 
['q, that [asS]NGFR~ migrated as a 48 kDa protein when N- 
glycosylated (lane 1) and like a 45 kDa protein in the absence 
c,f N-glycosylation (lane 2). When retained in the ER at 37°C 
ciue to a see18 block (strain H640), NGFRe also migrated as a 
48 kDa protein in the absence of TM (Fig. 4B, lane 1) and 
hke a 45 kDa protein in the presence of TM (lane 2). 
[ H]Mannose was incorporated into N-glycosylated NGFR~ 
irl strain H487 (Fig. 4A, lane 3), whereas [aH]mannosylation 
was negligible in the presence of TM (lane 4). Since the 
[ H]mannose labeling of NGFRe was due to the 9 or so man- 
rose residues of the single primary N-glycan, NGFR~ appar- 
ently lacked O-glycans. Hspl50A-NGFRe (Fig. 1B) served as 
~: control: lane 1 (Fig. 4C) shows [35S]Met/Cys-labeled 
hspl50A-NGFRe, retained at 37°C in the ER in strain H538 
(¢ecl8) and migrating like a 130 kDa protein. A considerable 
amount of [3H]mannose was incorporated into it because of 
e~tensive O-glycosylation (lane 2). 
NGFRe apparently acquires a few O-glycans in mammalian 
cells, since O-glycanase digestion has been reported to reduce 
its apparent molecular weight by 2-3 kDa [16,17]. Little in- 
formation is so far available on O-glycosylation of mamma- 
lian proteins in yeast. Selected sites of the FeE receptor, para- 
thyroid hormone, cell-adhesive lysozyme and insulin-like 
growth factor, unoccupied in the authentic molecules, were 
O-glycosylated in yeast [18-21], whereas the same sites of 
granulocyte/macrophage colony-stimulating factor were O- 
glycosylated in yeast and mammalian cells [22]. 
3.4. Glycosylation of misfolded NGFRe 
Next we studied whether the NGFRe portion of hspl50A- 
NGFR,, was susceptible for O-glycosylation when its confor- 
mation was distorted by preventing disulfide formation. We 
have shown before that treatment of yeast cells with the re- 
ducing agent dithiothreitol (DTT) inhibits disulfide formation 
of newly synthesized proteins leading to their ER retention, 
without affecting the secretion and glycosylation apparatus of 
S. cerevisiae [14]. Authentic NGFRo has up to 12 disulfide 
bonds, and yeast-derived hspl50A-NGFR~ is also disulfide- 
bonded [9]. Hspl50A-NGFRe (H426) was labeled with 
[35S]Met/Cys in the presence of DTT, followed by chase in 
the absence of DTT but presence of CHX. The fusion protein 
molecules released from the DTT block could be immunopre- 
cipitated from the culture medium, and migrated in SDS- 
PAGE more slowly (Fig. 5, lane 7, 210-260 kDa) than 
hspI50A-NGFR~ molecules ynthesized and secreted normally 
in the absence of DTT (lane 5, 160 240 kDa). This suggests 
that the reduced molecules were more extensively glycosylated 
than the native ones. To differentiate whether N- or O-glyco- 
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Fig. 4. Incorporation of [3H]mannose into NGFR~. (A) Strain H487 
(NGFRe) was labeled for 90 min at 37°C with [~SS]Met/Cys (lanes 
1,2), or with [3H]mannose (lanes 3,4), in the absence (lanes 1,3) or 
presence of TM (lanes 2,4). (B) Strain H640 (NGFRe/sec18) was la- 
beled, after a pre-incubation for 10 min at 37°C, with [35S]Met/Cys 
for 90 min at 37°C in the absence (lane 1) or presence of TM (lane 
2), as in lanes 1,2 of panel (A). (C) Strain H538 (hspI50A-NGFR~/ 
secl8) was labeled with [aSS]Met/Cys (lane 1) or [3H]mannose (lane 
2) as in lanes 1,3 of panel (A). The cells were lyzed and immuno- 
precipitated with anti-hspl50A-NGFRe (A,B) or anti-hspl50 antiser- 
um (C), and the proteins eparated by SDS-PAGE (12% gel in pa- 
nels A,B, and 8% gel in panel C) and visualized by fluorography. 
Molecular weight markers are on the left. 
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domains [24]. This would suggest post-translational, rather 
than co-translational O-glycosylation. 
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Fig. 5. Glycosylation of reduced hspl50A-NGFRe. Strain H426 
(hsp150A-NGFl~) was labeled for 1 h at 24°C in the presence of 
TM with [ass]Met/Cys (lanes 1,2). A parallel sample was labeled 
similarly, but in the presence of DTT, whereafter DTT was washed 
away and the sample chased with CHX in the presence of TM at 
24°C for 60 rain (lanes 3,4), A third sample was labeled as in lanes 
1,2, but in the absence of TM (lanes 5,6). A fourth sample was la- 
beled and chased as in lanes 3,4, but in the absence of TM (lanes 
7,8). The culture media (M) and lyzed cells (C) were subjected to 
immunoprecipitation with anti-hsp150 antiserum, and the proteins 
were analyzed by SDS-PAGE and fluorography. Molecular weight 
markers are on the left. 
sylation was increased on the reduced molecules, hspl50A- 
NGFRe was labeled with [ass]Met/Cys in the presence of 
DTT and TM. DTT was removed and the label chased with 
CHX in the presence of TM. In the absence of N-glycosyla- 
tion, hspl50A-NGFRe released from the DTT block migrated 
in SDS-PAGE (Fig. 5, lane 3) like native hspl50A-NGFRe 
secreted in the absence of DTT (lane 1). This suggests that 
N-glycosylation, but not O-glycosylation, was more efficient 
on the reduced hsp150A-NGFRe molecules. We could not 
differentiate whether increased N-glycosylation was due to 
more frequent utilization of the single N-glycosylation site, 
or to enhanced elongation of the glycan in the Golgi. Increase 
in N-glycosylation of inefficiently used sites on misfolded tis- 
sue-type plasminogen activator has been detected in mamma- 
lian cells [23]. 
Clearly, glycosylation of serines and threonines is highly 
selective in S. cerevisiae. In case it occurs strictly co-translo- 
cationally, it must be controlled by the amino acid sequence, 
whereas in the case of a post-translocational event, other fea- 
tures of the folded molecule regulate it. The two portions of 
hspl50A-NGFR~ are very different: the carrier appears not to 
adopt any regular secondary structure [11], whereas NGFR~ is 
likely to fold to an elongated end-to-end assembly of four 
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